global-alert
global messaging alerts

Profile

Anne Hoffman, PhD
Chief Pharmaceutical Officer

Dr. Anne Hofmann is an accomplished global business leader and scientist who brings 15 years of pharmaceutical industry experience to her role at ApiJect. Focused on existing and new product development and introductions, she works closely with our device engineers, senior leaders, external partners, regulatory stakeholders, and quality teams.

She has led teams overseeing biologicals, vaccines, and generic injectable products, serving most recently as Vice President of Digitalization Excellence and Strategy at Bristol Myers Squibb (2020-2022).

From 2018-2020 she served as the Master Architect of Manufacturing Systems Design and Commercialization for Merck. She has held numerous other roles in supply chain, procurement, and global expansion at Abcam (2016-2018), Pfizer Inc. (2012-2016) and Novartis Vaccines & Diagnostics (2007-2012).

Dr. Hofmann received her PhD in Biochemistry & Molecular Biology from Johns Hopkins University, where she was an Adjunct Professor in Biotechnology. She completed a Post-Doctoral program at The Rockefeller University.

Additional Technical Resources

Video
Print
random footer image
Social media & sharing icons powered by UltimatelySocial
Twitter
YouTube
YouTube
LinkedIn
LinkedIn